1. Home
  2. ALDX vs SEVN Comparison

ALDX vs SEVN Comparison

Compare ALDX & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • SEVN
  • Stock Information
  • Founded
  • ALDX 2004
  • SEVN 1986
  • Country
  • ALDX United States
  • SEVN United States
  • Employees
  • ALDX N/A
  • SEVN N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • SEVN Real Estate Investment Trusts
  • Sector
  • ALDX Health Care
  • SEVN Real Estate
  • Exchange
  • ALDX Nasdaq
  • SEVN Nasdaq
  • Market Cap
  • ALDX 160.8M
  • SEVN 179.3M
  • IPO Year
  • ALDX 2014
  • SEVN N/A
  • Fundamental
  • Price
  • ALDX $4.76
  • SEVN $11.13
  • Analyst Decision
  • ALDX Strong Buy
  • SEVN Strong Buy
  • Analyst Count
  • ALDX 2
  • SEVN 3
  • Target Price
  • ALDX $9.50
  • SEVN $14.75
  • AVG Volume (30 Days)
  • ALDX 1.2M
  • SEVN 63.3K
  • Earning Date
  • ALDX 07-31-2025
  • SEVN 07-28-2025
  • Dividend Yield
  • ALDX N/A
  • SEVN 12.56%
  • EPS Growth
  • ALDX N/A
  • SEVN N/A
  • EPS
  • ALDX N/A
  • SEVN 1.15
  • Revenue
  • ALDX N/A
  • SEVN $30,074,000.00
  • Revenue This Year
  • ALDX N/A
  • SEVN $7.45
  • Revenue Next Year
  • ALDX N/A
  • SEVN $1.12
  • P/E Ratio
  • ALDX N/A
  • SEVN $9.70
  • Revenue Growth
  • ALDX N/A
  • SEVN N/A
  • 52 Week Low
  • ALDX $1.14
  • SEVN $10.18
  • 52 Week High
  • ALDX $7.20
  • SEVN $14.66
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 78.74
  • SEVN 45.10
  • Support Level
  • ALDX $4.12
  • SEVN $12.40
  • Resistance Level
  • ALDX $4.60
  • SEVN $12.76
  • Average True Range (ATR)
  • ALDX 0.29
  • SEVN 0.33
  • MACD
  • ALDX 0.08
  • SEVN 0.02
  • Stochastic Oscillator
  • ALDX 90.91
  • SEVN 15.30

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About SEVN Seven Hills Realty Trust

Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.

Share on Social Networks: